Tags: Sickle-Cell Disease, sickle cell disease, Casgevy, U.S., First Crispr Gene-Editing Drug, CRISPR gene-editing, US, treatment, regulators, FDA Approves World, gene therapies,

Help Keep This Site Alive
I built and maintain this site on my own, but rising hosting costs are becoming unsustainable. Your donation would help cover costs and allow me to focus on improving the site.